Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of California, Los Angeles
With
Pfizer
The purpose of this study is to evaluate the use of sildenafil in patients with pulmonary fibrosis and PH being considered for lung transplantation. We hypothesize that not only will sildenafil improve functionality and QOL in the pre-transplant setting but it may also improve primary graft dysfunction after lung transplantation.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with Idiopathic Pulmonary Fibrosis referred for lung transplantation at our medical center
Minimal 6 minute walk distance of 50 meters; must be able to conduct supine exercise during heart catheterization
You may not be if
Non ambulatory
Prior adverse reaction/allergy to sildenafil or other PDE-5 Inhibitors
Any other pulmonary vasodilator within one month of enrollment
Clareo Health | Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
